多篇SCI齐发！玉研肺部雾化给药器，为何成为顶尖科研团队的“共同选择”？

1. Lu, Peng, et al. "Circulating Mitochondrial N-Formyl Peptides Are Associated with Acute Respiratory Distress Syndrome after Cardiopulmonary Bypass and Regulate Endothelial Barrier through FPR2." American Journal of Respiratory Cell and Molecular Biology 72.5 (2025): 533-550.

DOI: 10.1165/rcmb.2024-0076OC

2.Zhang, Chenghao, et al. "Emodin nanocrystals enhanced mucus penetration and ameliorated bleomycin-induced pulmonary fibrosis by pulmonary delivery." Journal of Drug Targeting (2025): 1-11.

DOI: 10.1080/1061186X.2025.2497369

3. Yan, Jiahui, et al. "Effects of Simiao Pill on rheumatoid arthritis complicated with interstitial lung disease via the ATX/LPA/LPA1 and RhoA/ROCK2 signaling pathways." (2025).

DOI: 10.21203/rs.3.rs-6597839/v1

4. Xu, Siqi, et al. "Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin." Journal of Virology 99.5 (2025): e02090-24.

DOI: 10.1128/jvi.02090-24

5. Xu Y, et al. "Multifunctional Gold Nanoclusters for a Lung Tissue Distribution Study of a Novel Anti-asthma Inhaled Antibody. " Anal Chem. 2025 Sep 16;97(36):19635-19653. 

DOI: 10.1021/acs.analchem.5c03043

6. Wang B, et al. "A softness zwitterionic micelles efficiently deliver inhaled nintedanib by enhancing airway mucus penetration. " Sci Adv. 2026 Jan 2;12(1):eady1030. 

DOI: 10.1126/sciadv.ady1030

7. Yang Y, et al. "Preparation, characterisation and pharmacokinetics evaluation of dry power inhalation formulations of polymyxin B. " Pharm Dev Technol. 2025 Feb;30(2):177-185. 

doi: 10.1080/10837450

8.Pan, Tingyu, et al. "Identification of potential mechanisms of Schisandrin B in the treatment of idiopathic pulmonary fibrosis by integrating network pharmacology and experimental validation." Naunyn-Schmiedeberg's Archives of Pharmacology (2024): 1-15.

DOI: 10.1007/s00210-024-03605-7

9.Sun, Xiaolin, et al. "GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway." Redox Biology 71 (2024): 103116.

DOI: 10.1016/j.redox.2024.103116

10.Meng, Qinghe, et al. "Induced pluripotent stem cell-derived mesenchymal stem cells-derived extracellular vesicles attenuate LPS-induced lung injury and endotoxemia in mice." Shock 62.2 (2024): 294-303.

DOI: 10.1097/SHK.0000000000002381

11. Zhu, Chuanda, et al. "An elastase nanocomplex with metal cofactors for enhancement of target protein cleavage activity and synergistic antitumor effect." Chemical Engineering Journal (2024): 149902.

DOI:10.1016/j.cej.2024.149902.

12. Han, Meng-Meng et al. “Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling.” Journal of controlled release : official journal of the Controlled Release Society vol. 366 (2024): 732-745. DOI:10.1016/j.jconrel.2024.01.032

13. Zhang, Huizhe, et al. "Integrative analysis of the efficacy and pharmacological mechanism of Xuefu Zhuyu decoction in idiopathic pulmonary fibrosis via evidence-based medicine, bioinformatics, and experimental verification." Heliyon 10.19 (2024).

DOI: 10.1016/j.heliyon.2024.e38122

14. Yeshwante, Shekhar. "SYSTEMS-BASED APPROACH TO DESIGN AND OPTIMIZATION OF TREATMENT FOR PULMONARY INFECTIONS: STRATEGY TO COMBAT ANTIMICROBIAL RESISTANCE." (2024).

15. Chen, Huanjie, et al. "Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats." Frontiers in Pharmacology 13 (2023): 1070736.

DOI: 10.3389/fphar.2022.1070736

16. Wang, Shuo, et al. "Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway." Translational Lung Cancer Research 12.3 (2023): 427.

DOI: 10.21037/tlcr-22-675

17. Wang, Ping, et al. "Effect of intratracheal instillation of ZnO nanoparticles on acute lung inflammation induced by lipopolysaccharides in mice." Toxicological Sciences 173.2 (2020): 373-386.

DOI: 10.1093/toxsci/kfz234

18. Ma, Julia, et al. "Prophylactic nCMT-3 attenuates sepsis-induced acute kidney injury in association with NLRP3 inflammasome activation and apoptosis." Shock 59.6 (2023): 922-929.

DOI: 10.1097/SHK.0000000000002118

19. Zhang, Huizhe, et al. "Danggui buxue decoction ameliorates idiopathic pulmonary fibrosis through MicroRNA and messenger RNA regulatory network." Evidence‐Based Complementary and Alternative Medicine 2022.1 (2022): 3439656.

DOI: 10.1155/2022/3439656

20. Ba, Xin, et al. "Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway." Journal of Ethnopharmacology 309 (2023): 116274.

DOI: 10.1016/j.jep.2023.116274

21. Santin, Yohan, et al. "Inhalation of acidic nanoparticles prevents doxorubicin cardiotoxicity through improvement of lysosomal function." Theranostics 13.15 (2023): 5435.

DOI: 10.7150/thno.86310

22.CHENG, Zhipeng, et al. "Therapeutic effect of perfluorocarbon aerosol inhalation on lung injury induced by seawater inhalation in rats." ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL 44.5 (2023): 508-513.

DOI: 10.3969/j.issn.2095-5227.2023.05.012

23. Feng, Xin et al. “First magnetic particle imaging to assess pulmonary vascular leakage in vivo in the acutely injured and fibrotic lung.” Bioengineering & translational medicine vol. 9,2 e10626. 29 Nov. 2023.

DOI:10.1002/btm2.10626

24. Fan, Weiyang et al. “Naringenin regulates cigarette smoke extract-induced extracellular vesicles from alveolar macrophage to attenuate the mouse lung epithelial ferroptosis through activating EV miR-23a-3p/ACSL4 axis.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 124 (2024): 155256.

DOI:10.1016/j.phymed.2023.155256

25. Li, Cheng et al. “Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.” Cell vol. 185,8 (2022): 1389-1401.e18.

DOI:10.1016/j.cell.2022.03.009

26. Liu, Chang et al. “An Inhalable Hybrid Biomimetic Nanoplatform for Sequential Drug Release and Remodeling Lung Immune Homeostasis in Acute Lung Injury Treatment.” ACS nano vol. 17,12 (2023): 11626-11644. 

DOI:10.1021/acsnano.3c02075

27. Peng, Boya et al. “Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy.” Journal of extracellular vesicles vol. 11,4 (2022): e12187. DOI:10.1002/jev2.12187

28. Yang, Guang, et al. "Noncovalent co-assembly of aminoglycoside antibiotics@ tannic acid nanoparticles for off-the-shelf treatment of pulmonary and cutaneous infections." Chemical Engineering Journal 474 (2023): 145703.

DOI:10.1016/j.cej.2023.145703.

29. Sun, Han et al. “Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome.” Theranostics vol. 13,14 4974-4992. 4 Sep. 2023, 

DOI:10.7150/thno.86466

30. Yue, Dayong et al. “Diesel exhaust PM2.5 greatly deteriorates fibrosis process in pre-existing pulmonary fibrosis via ferroptosis.” Environment international vol. 171 (2023): 107706. DOI:10.1016/j.envint.2022.107706

31. Zhang, Mengjun et al. “Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.” Journal of controlled release : official journal of the Controlled Release Society vol. 352 (2022): 422-437.

DOI:10.1016/j.jconrel.2022.10.020

32. Gu, Peiyu et al. “Protective function of interleukin-22 in pulmonary fibrosis.” Clinical and translational medicine vol. 11,8 (2021): e509.

DOI:10.1002/ctm2.509

33. Wu, Lan et al. “Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration.” ACS applied materials & interfaces vol. 13,3 (2021): 3722-3737. DOI:10.1021/acsami.0c21259

34. Tian, Xidong et al. “Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.” ACS applied materials & interfaces vol. 13,48 (2021): 56858-56872. DOI:10.1021/acsami.1c16351

35. Lin, Wei-Ting et al. “Modulation of experimental acute lung injury by exosomal miR-7704 from mesenchymal stromal cells acts through M2 macrophage polarization.” Molecular therapy. Nucleic acids vol. 35,1 102102. 14 Dec. 2023. 

DOI:10.1016/j.omtn.2023.102102

36. Yang, Huilin et al. “Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 139 (2021): 111569. DOI:10.1016/j.biopha.2021.111569

37. Feng, Xin et al. “First magnetic particle imaging to assess pulmonary vascular leakage in vivo in the acutely injured and fibrotic lung.” Bioengineering & translational medicine vol. 9,2 e10626. 29 Nov. 2023,.

DOI:10.1002/btm2.10626

38. Xiao, Xue et al. “SerpinB1 is required for Rev-erbα-mediated protection against acute lung injury induced by lipopolysaccharide-in mice.” British journal of pharmacology vol. 180,24 (2023): 3234-3253.

 DOI:10.1111/bph.16175

39. Su, Ruonan et al. “Venetoclax nanomedicine alleviates acute lung injury via increasing neutrophil apoptosis.” Biomaterials science vol. 9,13 (2021): 4746-4754. DOI:10.1039/d1bm00481f

40. Xu, Yingying et al. “PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA.” Drug delivery vol. 30,1 (2023): 2219870.

DOI:10.1080/10717544.2023.2219870

41. Wu, Yanqi et al. “SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation.” Respiratory research vol. 21,1 130. 27 May. 2020。

DOI:10.1186/s12931-020-01372-6

42. Chen, Huanjie et al. “Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats.” Frontiers in pharmacology vol. 13 1070736. 6 Jan. 2023.

DOI:10.3389/fphar.2022.1070736

43. Han, Meishan et al. “Engineering of Stimulus-Responsive Pirfenidone Liposomes for Pulmonary Delivery During Treatment of Idiopathic Pulmonary Fibrosis.” Frontiers in pharmacology vol. 13 882678. 25 Apr. 2022.

DOI:10.3389/fphar.2022.882678

44. Cai, Zimin, et al. "Enhanced protective activity of 1, 8-cineole on emphysema using hyaluronic acid-coated liposomes via quantitative pulmonary administration in mice." Journal of Drug Delivery Science and Technology 72 (2022): 103402.

DOI:10.1016/j.jddst.2022.103402

45. Wu, Lan, et al. "Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles." European Journal of Pharmaceutics and Biopharmaceutics 152 (2020): 108-115. 

DOI:10.1016/j.ejpb.2020.05.004

46. Peng, Jianqing et al. “Carboxymethyl Chitosan Modified Oxymatrine Liposomes for the Alleviation of Emphysema in Mice via Pulmonary Administration.” Molecules (Basel, Switzerland) vol. 27,11 3610. 4 Jun. 2022.

DOI:10.3390/molecules27113610

47. Chen, Huanjie et al. “Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats.” Frontiers in pharmacology vol. 13 1070736. 6 Jan. 2023.

DOI:10.3389/fphar.2022.1070736

48. Wang, Ping et al. “Effect of Intratracheal Instillation of ZnO Nanoparticles on Acute Lung Inflammation Induced by Lipopolysaccharides in Mice.” Toxicological sciences : an official journal of the Society of Toxicology vol. 173,2 (2020): 373-386. 

DOI:10.1093/toxsci/kfz234

49. Meng, Qinghe et al. “Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.” Shock (Augusta, Ga.) vol. 57,5 (2022): 749-758.

 DOI:10.1097/SHK.0000000000001927

50. Chen, Ping et al. “Chronic exposure to ampicillin alters lung microbial composition in laboratory rat.” Experimental lung research vol. 49,1 (2023): 116-130. 

DOI:10.1080/01902148.2023.2219790